CABA
Price
$1.11
Change
-$0.08 (-6.72%)
Updated
Apr 4 closing price
Capitalization
56.32M
38 days until earnings call
GUTS
Price
$1.12
Change
-$0.02 (-1.75%)
Updated
Apr 4 closing price
Capitalization
54.79M
43 days until earnings call
Ad is loading...

CABA vs GUTS

Header iconCABA vs GUTS Comparison
Open Charts CABA vs GUTSBanner chart's image
Cabaletta Bio
Price$1.11
Change-$0.08 (-6.72%)
Volume$1.64M
Capitalization56.32M
Fractyl Health
Price$1.12
Change-$0.02 (-1.75%)
Volume$212.76K
Capitalization54.79M
CABA vs GUTS Comparison Chart
Loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CABA vs. GUTS commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CABA is a StrongBuy and GUTS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (CABA: $1.11 vs. GUTS: $1.12)
Brand notoriety: CABA and GUTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CABA: 150% vs. GUTS: 81%
Market capitalization -- CABA: $56.32M vs. GUTS: $54.79M
CABA [@Biotechnology] is valued at $56.32M. GUTS’s [@Biotechnology] market capitalization is $54.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CABA’s FA Score shows that 1 FA rating(s) are green whileGUTS’s FA Score has 0 green FA rating(s).

  • CABA’s FA Score: 1 green, 4 red.
  • GUTS’s FA Score: 0 green, 5 red.
According to our system of comparison, CABA is a better buy in the long-term than GUTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CABA’s TA Score shows that 4 TA indicator(s) are bullish while GUTS’s TA Score has 4 bullish TA indicator(s).

  • CABA’s TA Score: 4 bullish, 4 bearish.
  • GUTS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CABA and GUTS are a good buy in the short-term.

Price Growth

CABA (@Biotechnology) experienced а -28.39% price change this week, while GUTS (@Biotechnology) price change was -9.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.00%. For the same industry, the average monthly price growth was -16.69%, and the average quarterly price growth was -18.23%.

Reported Earning Dates

CABA is expected to report earnings on Aug 07, 2025.

GUTS is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-11.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($56.3M) and GUTS($54.8M) have the same market capitalization . GUTS YTD gains are higher at: -45.631 vs. CABA (-51.101). GUTS has higher annual earnings (EBITDA): -92.85M vs. CABA (-112.92M). CABA has more cash in the bank: 183M vs. GUTS (67.5M). CABA has less debt than GUTS: CABA (15.2M) vs GUTS (62.5M). GUTS has higher revenues than CABA: GUTS (93K) vs CABA (0).
CABAGUTSCABA / GUTS
Capitalization56.3M54.8M103%
EBITDA-112.92M-92.85M122%
Gain YTD-51.101-45.631112%
P/E RatioN/AN/A-
Revenue093K-
Total Cash183M67.5M271%
Total Debt15.2M62.5M24%
TECHNICAL ANALYSIS
Technical Analysis
CABAGUTS
RSI
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
88%
Bullish Trend 14 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GUTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSRRX8.30-0.22
-2.61%
Fidelity Strategic Real Return
MRVYX11.68-0.62
-5.04%
Mirova International Sustainable Eq Y
WBELX8.64-0.46
-5.05%
William Blair Emerging Mkts Ldrs I
JEPIX12.97-0.78
-5.67%
JPMorgan Equity Premium Income I
JSGIX22.73-1.40
-5.80%
JHancock U.S. Growth I

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
-6.72%
KYTX - CABA
47%
Loosely correlated
+0.51%
ARWR - CABA
44%
Loosely correlated
-11.44%
IMNM - CABA
41%
Loosely correlated
-4.97%
AUTL - CABA
39%
Loosely correlated
-11.92%
CCCC - CABA
39%
Loosely correlated
-4.73%
More

GUTS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GUTS has been loosely correlated with PRME. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GUTS jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GUTS
1D Price
Change %
GUTS100%
-1.75%
PRME - GUTS
36%
Loosely correlated
-12.42%
GLUE - GUTS
36%
Loosely correlated
+1.54%
CRSP - GUTS
35%
Loosely correlated
-0.03%
KYTX - GUTS
34%
Loosely correlated
+0.51%
CABA - GUTS
34%
Loosely correlated
-6.72%
More